Finance

Lists
BVS:NASDAQ
Bioventus Inc
$10.87
+0.09%
(+0.010) 1D
Nov 13, 11:38:36 AM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BVS...
Open
$11.00
High
$11.00
Low
$10.78
Mkt. cap
915.07M
Avg. vol.
559.40K
Volume
68.73K
52-wk high
$15.89
52-wk low
$6.47
Beta
0.66
Shares outstanding
68.47M
No. of employees
960
Open
$11.00
High
$11.00
Low
$10.78
Mkt. cap
915.07M
Avg. vol.
559.40K
Volume
68.73K
52-wk high
$15.89
52-wk low
$6.47
Beta
0.66
Shares outstanding
68.47M
No. of employees
960
News stories
From web sources and news partners
About Bioventus Inc
CEO-
Employees960
Founded2011
Headquarters-
SectorHealth Care
IndustryMedical device
Analyst ratings
Based on 4 analysts giving stock ratings to BVS in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for BVS in the last 3 months.
Highest
Current $10.87
$18.00 (+65.59%)
Average
$16.25 (+49.49%)
Lowest
$15.00 (+37.99%)
Analyst
Recommendation
Action
Price target
Projected
Date
Chase Knickerbocker
Craig-Hallum
Buy
Maintained
$16.00
+47.2%
11/03/2026
Michael Petusky
Barrington
Buy
Maintained
$16.00
+47.2%
11/03/2026
William Plovanic
Canaccord Genuity
Buy
Reiterated
$18.00
+65.6%
11/03/2026
Unknown Analyst
Cantor Fitzgerald
Buy
Reiterated
$15.00
+38%
08/17/2026
Caitlin Roberts
Canaccord Genuity
Buy
Maintained
$19.00
+74.8%
08/17/2026
Lawrence Solow
CJS Securities
Buy
Initiated
$14.00
+28.8%
03/27/2026
Last report
Nov 2, 2026
Fiscal period
Q3 2026
$0.17 / $0.16
+6.25%beat
Revenue / Est. (USD)
142.44M / 149.52M
-4.73%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
157.90M
132.09M
153.21M
142.44M
Cost of goods sold
49.12M
41.32M
47.54M
45.31M
Cost of revenue
49.12M
41.32M
47.54M
45.31M
Research and development expenses
3.01M
2.47M
3.17M
3.44M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
82.76M
78.31M
82.72M
82.94M
Operating expense
87.06M
81.88M
86.93M
87.43M
Total operating expenses
136.18M
123.20M
134.47M
132.74M
Operating income
21.72M
8.89M
18.73M
9.70M
Other non operating income
-2.01M
427.00K
-
-
EBT including unusual items
14.14M
4.52M
15.31M
6.16M
EBT excluding unusual items
16.38M
4.99M
14.92M
6.16M
Income tax expense
-3.18M
571.00K
-20.90M
-701.00K
Effective tax rate
-22.45%
12.64%
-136.51%
-11.38%
Other operating expenses
-
-
-
-
Net income
14.76M
3.11M
33.44M
5.99M
Net profit margin
9.34%
2.36%
21.83%
4.20%
Earnings per share
0.24
0.15
0.22
0.17
Interest and investment income
-
-
-
-
Interest expense
-5.31M
-4.33M
-4.07M
-3.76M
Net interest expenses
-5.31M
-4.33M
-4.07M
-3.76M
Depreciation and amortization charges
1.30M
1.11M
1.04M
1.05M
EBITDA
27.05M
20.09M
29.68M
20.02M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps